Exscientia Ltd Adr Stock Number Of Shares Shorted
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Exscientia's long-term financial health and intrinsic value.
Exscientia |
Exscientia Ltd ADR Company Number Of Shares Shorted Analysis
Exscientia's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Exscientia Number Of Shares Shorted | 2.81 M |
Most of Exscientia's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Exscientia Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Exscientia Ltd ADR has 2.81 M of outstending shares currently sold short by investors. This is 12.12% lower than that of the Biotechnology sector and 44.85% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 40.25% higher than that of the company.
Exscientia Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Exscientia's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Exscientia could also be used in its relative valuation, which is a method of valuing Exscientia by comparing valuation metrics of similar companies.Exscientia is currently under evaluation in number of shares shorted category among its peers.
Exscientia Fundamentals
Return On Equity | -0.46 | |||
Return On Asset | -0.21 | |||
Operating Margin | (10.66) % | |||
Current Valuation | 346.92 M | |||
Shares Outstanding | 130.82 M | |||
Shares Owned By Insiders | 25.90 % | |||
Shares Owned By Institutions | 20.80 % | |||
Number Of Shares Shorted | 2.81 M | |||
Price To Book | 1.95 X | |||
Price To Sales | 37.10 X | |||
Revenue | 20.08 M | |||
Gross Profit | 10.25 M | |||
EBITDA | (145.45 M) | |||
Net Income | (145.96 M) | |||
Cash And Equivalents | 601.89 M | |||
Cash Per Share | 4.91 X | |||
Total Debt | 18.92 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 9.08 X | |||
Book Value Per Share | 1.95 X | |||
Cash Flow From Operations | (117.6 M) | |||
Short Ratio | 5.77 X | |||
Earnings Per Share | (1.51) X | |||
Price To Earnings To Growth | 0.10 X | |||
Target Price | 4.35 | |||
Number Of Employees | 483 | |||
Beta | 0.84 | |||
Market Capitalization | 633.18 M | |||
Total Asset | 510.72 M | |||
Retained Earnings | (110.47 M) | |||
Working Capital | 339.87 M | |||
Net Asset | 510.72 M |
Currently Active Assets on Macroaxis
USOI | Credit Suisse X Links | |
ULTY | Tidal Trust II | |
CONY | YieldMax N Option | |
BCAT | BlackRock Capital Allocation | |
PDI | Pimco Dynamic Income |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Exscientia Stock
If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |